Healthcare -
Biotechnology - NASDAQ - US
$ 1.16
-0.431 %
$ 1.47 M
Market Cap
-0.08
P/E
KTTA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KTTA - Pasithea Therapeutics Corp.
399 K
LAST VALUE
353.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR